The Health Resources and Services Administration will require hospitals in the 340B Drug Pricing Program to register their off-site outpatient departments, known as child sites, with the 340B Office of Pharmacy Affairs within 90 days in order to access 340B drug pricing, the Health Resources and Services Administration announced Oct. 26. The agency said the 90-day grace period will give 340B hospitals time to register these child sites and list them on the hospital’s Medicare cost report, after which noncomplying hospitals may be subject to audit and compliance action.
 
HRSA provided flexibility regarding the registration of 340B child sites during the COVID-19 public health emergency, which ended in May. Three days before the end of the PHE, HRSA issued a notice instructing hospitals to stop purchasing 340B drugs at outpatient facilities that are not yet included in the hospital’s Medicare cost report and registered with HRSA. AHA then urged the agency to clarify that 340B hospitals can continue to purchase 340B drugs at off-site clinics that have not yet appeared on their most recent Medicare cost report.

Related News Articles

Blog
A new study published in the New England Journal of Medicine demonstrates a stunning lack of understanding of the 340B drug pricing program and the…
Headline
A bipartisan group of senators Feb. 2 released for stakeholder feedback a discussion draft of legislation to clarify in statute Congress’ intent for the 340B…
Headline
AHA Dec. 22 filed a friend-of-the-court brief in support of a Louisiana law that prohibits drug companies from denying Louisiana hospitals the same 340B…
Headline
Following last year’s unanimous Supreme Court decision in favor of the AHA and others, the Department of Health and Human Services Nov. 2 issued a final…
Perspective
With only 11 days that the House and Senate are in session together before the fiscal year concludes, much of the attention in Washington is on how Congress…
Headline
The Centers for Medicare & Medicaid Services has extended to Sept. 11 the deadline to submit comments on its proposed remedy for the unlawful payment…